BIS

ProShares UltraShort NASDAQ Biotechnology
*Unless otherwise stated, data provided by FactSet.

BIS Fund Description

BIS provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

BIS Factset Analytics Insight

BIS is one available fund that provides exposure to the biotech space — aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.

PERFORMANCE [as of 05/20/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
BIS 20.22% 5.45% 43.70% 33.98% -28.01% -23.47% -34.03%
BIS (NAV) 21.65% 7.46% 46.23% 30.22% -26.90% -23.22% -33.91%
NASDAQ Biotechnology Index -10.90% -6.75% -21.61% -22.25% 5.44% 4.59% 11.94%
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BIS Summary Data

ProShares
04/07/10
Open-Ended Fund
0.95%
$8.92M
0.30%
N/A

BIS Portfolio Data

0.47%
N/A

BIS Index Data

Market Cap
NASDAQ - Listed
N/A

BIS Fund Structure

Yes
No
-- / --
N/A
N/A
High
-2
Daily

BIS Tax Exposures

20.00% / 39.60%
--
No

BIS Factset Analytics Block Liquidity

As of 05/24/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BIS. BIS is rated a N/A out of 5.

BIS Tradability

16,001
$446.46K
13,112
$326.80K
0.30%
$0.07
0.01%
1.58% / -1.13%
None
92.00%
50,000
0.26
0.03%
--
315
$29.37
N/A